These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 15291802)
41. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074 [TBL] [Abstract][Full Text] [Related]
42. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Fu JF; Hsu JJ; Tang TC; Shih LY Genes Chromosomes Cancer; 2003 Jun; 37(2):214-9. PubMed ID: 12696071 [TBL] [Abstract][Full Text] [Related]
43. Subcellular localization of the MEN, MLL/MEN and truncated MLL proteins expressed in leukemic cells carrying the t(11;19)(q23;p13.1) translocation. Kanda Y; Mitani K; Tanaka T; Tanaka K; Ogawa S; Yazaki Y; Hirai H Int J Hematol; 1997 Aug; 66(2):189-95. PubMed ID: 9277049 [TBL] [Abstract][Full Text] [Related]
44. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus. Joh T; Yamamoto K; Kagami Y; Kakuda H; Sato T; Yamamoto T; Takahashi T; Ueda R; Kaibuchi K; Seto M Oncogene; 1997 Oct; 15(14):1681-7. PubMed ID: 9349501 [TBL] [Abstract][Full Text] [Related]
45. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Daser A; Rabbitts TH Genes Dev; 2004 May; 18(9):965-74. PubMed ID: 15132992 [No Abstract] [Full Text] [Related]
46. Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation. Joh T; Kagami Y; Yamamoto K; Segawa T; Takizawa J; Takahashi T; Ueda R; Seto M Oncogene; 1996 Nov; 13(9):1945-53. PubMed ID: 8934541 [TBL] [Abstract][Full Text] [Related]
47. SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24. Ono R; Taki T; Taketani T; Kawaguchi H; Taniwaki M; Okamura T; Kawa K; Hanada R; Kobayashi M; Hayashi Y Cancer Res; 2002 Jan; 62(2):333-7. PubMed ID: 11809673 [TBL] [Abstract][Full Text] [Related]
48. t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL. Kumar AR; Yao Q; Li Q; Sam TA; Kersey JH Leuk Res; 2011 Mar; 35(3):305-9. PubMed ID: 20869771 [TBL] [Abstract][Full Text] [Related]
49. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia. Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106 [TBL] [Abstract][Full Text] [Related]
51. Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology? Bursen A; Moritz S; Gaussmann A; Moritz S; Dingermann T; Marschalek R Oncogene; 2004 Aug; 23(37):6237-49. PubMed ID: 15221006 [TBL] [Abstract][Full Text] [Related]
52. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Taki T; Kano H; Taniwaki M; Sako M; Yanagisawa M; Hayashi Y Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14535-40. PubMed ID: 10588740 [TBL] [Abstract][Full Text] [Related]
53. A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Maroc N; Morel A; Beillard E; De La Chapelle AL; Fund X; Mozziconacci MJ; Dupont M; Cayuela JM; Gabert J; Koki A; Fert V; Hermitte F Leukemia; 2004 Sep; 18(9):1522-30. PubMed ID: 15322560 [TBL] [Abstract][Full Text] [Related]
55. Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2;19;11) (p12;p13.3;q23). Lee SG; Park TS; Won SC; Song J; Lee KA; Choi JR; Marschalek R; Meyer C Cancer Genet Cytogenet; 2010 Feb; 197(1):32-8. PubMed ID: 20113834 [TBL] [Abstract][Full Text] [Related]
57. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Sobulo OM; Borrow J; Tomek R; Reshmi S; Harden A; Schlegelberger B; Housman D; Doggett NA; Rowley JD; Zeleznik-Le NJ Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8732-7. PubMed ID: 9238046 [TBL] [Abstract][Full Text] [Related]
58. Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL. Fu JF; Liang DC; Shih LY Am J Clin Pathol; 2007 Jan; 127(1):24-30. PubMed ID: 17145626 [TBL] [Abstract][Full Text] [Related]
59. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report. Naghashpour M; Lancet J; Moscinski L; Zhang L Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125 [TBL] [Abstract][Full Text] [Related]
60. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]